GlaxoSmithKline to commercialise Cann Group cannabis medication

Medicinal cannabis producer Cann Group and global pharmaceutical firm GlaxoSmithKline are progressing negotiations relating to the commercialisation of Cann’s Satipharm CBD capsules. Cann Group, which operates a major cannabis growing and processing centre at Mildura, Victoria (pictured) announced it was in negotiation with GlaxoSmithKline’s Australian arm Haleon. The negotiations involve an exclusive agreement covering distribution…

DroneShield’s DroneCannon features in Agile Shield

Drone detection and countermeasure company DroneShield has announced that one of its key products has been integrated into defence prime contractor Lockheed Martin Australia’s Agile Shield battlefield management programme. The incorporation of the company’s DroneCannon Mk2 wide area non-kinetic effector (pictured) was announced as part of a collaboration with LMA’s Science, Technology, Engineering, Leadership and…

There’s a buzz about ‘sustainable’ fuels – but they cannot solve aviation’s colossal climate woes

By Susanne Becken, Griffith University; Brendan Mackey, Griffith University, and David Simon Lee, Manchester Metropolitan University The global airline industry is fast recovering from the unprecedented pause to flying imposed by COVID-19. In some parts of the world, such as the Middle East, airlines are even expanding rapidly – well beyond pre-pandemic levels. But how…